Type1 Diabetes Clinical Trial
Official title:
Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are: - Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education? - Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education. Participants in the intervention group will: - receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies. - participate in four in-depth online group sessions with diabetes care and education specialists - complete questionnaires three times: at the time of study enrollment, week 4 and 6 months. Participants in the comparison group will: - receive standard education provided to all patients at CHLA - complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Youth with type 1 diabetes (T1D) are at increased risk for kidney failure, vision loss, heart disease, and premature mortality due to challenges with glycemic excursions. Continuous glucose monitoring (CGM) systems represent an important advance in diabetes technology with significant advantages over self-monitored blood glucose and the potential to optimize glycemic management. Despite these advances, youth with T1D, including patients at Children's Hospital Los Angeles (CHLA), fail to achieve recommended glycemic targets, highlighting the opportunity for testing innovative diabetes education programs aimed at increased technology uptake such as the CGM Academy intervention. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05536232 -
Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet
|
N/A | |
| Completed |
NCT04255381 -
Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)
|
N/A | |
| Completed |
NCT04625595 -
Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
|
Phase 1 | |
| Active, not recruiting |
NCT06177691 -
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
|
||
| Completed |
NCT04002557 -
Optimising Consultation Summaries to Promote Good Health
|
||
| Completed |
NCT05876273 -
Neural-net Artificial Pancreas (NAP)
|
N/A | |
| Withdrawn |
NCT03236558 -
The Role of the Thymus in Type I Diabetes.
|
N/A | |
| Completed |
NCT03179280 -
Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
|
N/A | |
| Completed |
NCT06253351 -
Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age With Type 1 Diabetes
|
||
| Completed |
NCT01357603 -
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM
|
Phase 1 | |
| Completed |
NCT04233034 -
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
|
Phase 3 | |
| Recruiting |
NCT06408558 -
Safe Use of New Technologies in Diabetes in Flight
|
N/A | |
| Active, not recruiting |
NCT03782636 -
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
|
Phase 2 | |
| Completed |
NCT04520971 -
Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes
|
N/A | |
| Recruiting |
NCT05766657 -
Evaluation of an Anti-inflammatory Diet in Autoimmune and Metabolic Diseases
|
N/A | |
| Completed |
NCT01838083 -
Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus
|
Phase 1 |